{"id":110243,"date":"2026-09-02T16:05:50","date_gmt":"2026-09-02T07:05:50","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/4582-20260902-01_wp_stock_option\/"},"modified":"2026-09-02T16:05:50","modified_gmt":"2026-09-02T07:05:50","slug":"4582-20260902-01_wp_stock_option","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/","title":{"rendered":"Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party"},"content":{"rendered":"<p>Acquisition and cancellation of stock acquisition rights completed; allocation of the 70th and 71st stock acquisition rights to EVO FUND. Total issue amount: 2,880,000 yen; potential shares: 96,000,000 shares; exercise price adjustment clause; exercise period: 2026\/09\/03\u20132029\/09\/03. Estimated funds raised: 6,768,880,000 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4582","jir_company_name":"SymBio Pharmaceuticals Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4582-20260902-01.pdf","jir_short_summary":"Acquisition and cancellation of stock acquisition rights completed; allocation of the 70th and 71st stock acquisition rights to EVO FUND. Total issue amount: 2,880,000 yen; potential shares: 96,000,000 shares; exercise price adjustment clause; exercise period: 2026\/09\/03\u20132029\/09\/03. Estimated funds raised: 6,768,880,000 yen.","jir_summary":"### Section heading\nThis news release covers the status of the acquisition and cancellation of stock acquisition rights, and the issuance of the 70th and 71st stock acquisition rights to a third party. It discloses the completion of acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, the third-party allocation to EVO FUND, and outlines the total number of issuances, issue price, potential shares, exercise period, and adjustment terms.\n\n### Second section heading\nThe exercise price adjustment clause governs the issuance conditions, with conditions based on the closing price on the adjustment date. The allocation is a third-party allocation, and the parties have entered into a purchase agreement and a total-underwriting agreement. Attention should be paid to potential effects on shareholder value, dilution, and exercise activity during the issuance period.","jir_financial_highlights":"Total number of issued stock acquisition rights: 960,000 units (Unknown)\nPotential shares: 96,000,000 shares (Unknown)\nTotal issue price: 2,880,000 yen (Unknown)","jir_category":"","jir_hashtags":"#SymBioPharmaceuticals, #StockAcquisitionRights, #StockOptions, #CapitalPolicy","jir_key_figures":"Total number of issued stock acquisition rights: 960,000 units (70th: 480,000 units, 71st: 480,000 units)\nPotential shares: 96,000,000 shares (100 shares per stock acquisition right)\nTotal issue price: 2,880,000 yen","jir_meta_title":"SymBio Pharmaceuticals: Acquisition\/Cancellation of Stock Acquisition Rights and Issuance of 70th\/71st Rights | September 2026","jir_meta_description":"SymBio Pharmaceuticals stock option-related notice. Completion of acquisitions\/cancellations for the 58th\/66th\/67th rights and allocation of the 70th\/71st rights to EVO FUND. Highlights include total issuance, potential shares, exercise period, and adjustment terms.","jir_og_title":"SymBio Pharmaceuticals: Notice of Acquisition\/Issuance of Stock Acquisition Rights","jir_og_description":"Details on the acquisition\/cancellation of stock acquisition rights and the allocation of the 70th\/71st rights to EVO FUND, including total issuance, potential shares, exercise period, and adjustment terms.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60013,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-110243","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/\",\"name\":\"Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-09-02T07:05:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/","url":"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/","name":"Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-09-02T07:05:50+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4582\/ir\/4582-20260902-01_wp_stock_option\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice regarding the completion of the acquisition and cancellation of the 58th, 66th and 67th stock acquisition rights, and the payment of the issue price for the 70th and 71st stock acquisition rights (with exercise price adjustment clause) issued to a third party"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"60013","title":"SYMBIO PHARMACEUTICALS LTD","ticker":"4582"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/110243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=110243"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/110243\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=110243"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=110243"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=110243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}